Holen Sie sich die Stockscreener-App
3.78
3.08%
-0.12
Handel nachbörslich:
3.79
0.01
+0.26%
Schlusskurs vom Vortag:
$3.90
Offen:
$3.8683
24-Stunden-Volumen:
18,844
Relative Volume:
0.78
Marktkapitalisierung:
$3.88M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-7.29M
KGV:
-0.1551
EPS:
-24.3686
Netto-Cashflow:
$-6.81M
1W Leistung:
-3.57%
1M Leistung:
+2.44%
6M Leistung:
+1.07%
1J Leistung:
-27.45%
1-Tages-Spanne:
$3.72
$3.8683
1-Wochen-Bereich:
$3.63
$4.03
52-Wochen-Spanne:
$2.36
$5.2989
Heartsciences Inc Stock (HSCS) Company Profile
Firmenname
Heartsciences Inc
Sektor
Branche
Telefon
682-237-7781
Adresse
550 RESERVE ST, SUITE 360, SOUTHLAKE
Vergleichen Sie HSCS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HSCS
Heartsciences Inc
|
3.78 | 3.88M | 0 | -7.29M | -6.81M | -24.37 |
|
ABT
Abbott Laboratories
|
134.11 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
103.63 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
391.81 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
88.28 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.02 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Heartsciences Inc Aktie (HSCS) Neueste Nachrichten
FDA Grants Breakthrough Device Designation for HeartSciences' AI-ECG Algorithm - Diagnostic and Interventional Cardiology
HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis - Investing News Network
HeartSciences recesives FDA BDD for Aortic Stenosis ECG algorithm - MSN
HeartSciences (HSCS) Gains FDA Breakthrough Status for AI ECG Al - GuruFocus
Heart Test Laboratories Receives FDA Breakthrough Designation - TipRanks
HeartSciences (HSCS) Gains FDA Breakthrough Status for AI ECG Algorithm | HSCS Stock News - GuruFocus
Revolutionary AI Algorithm Detects Silent Killer Heart Disease 2 Years Earlier, FDA Fast-Tracks Approval - Stock Titan
Heart Test Laboratories Files Certificate for Preferred Stock - TipRanks
HeartSciences announces grant by USPTO for ECG assessment of heart function - TipRanks
HeartSciences Inc. Announces the Grant by the United States Patent and Trademark Office of A foundational Patent Covering the Establishing the Estimation of Echocardiography parameters Indicative of Heart Function Using an ECG - marketscreener.com
Heart Test Laboratories Secures Foundational Patent for AI-ECG - TipRanks
HeartSciences (HSCS) Strengthens IP Portfolio with New Patent Grant | HSCS Stock News - GuruFocus
HeartSciences Inc. Secures Foundational Patent for AI-Driven ECG Technology Enhancing Heart Function Detection - Nasdaq
Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences' Patent Portfolio and IP Value - The Manila Times
Revolutionary AI Patent: HeartSciences Transforms ECG Technology for Earlier Heart Disease Detection - Stock Titan
HeartSciences signs first MyoVista Insights platform customer - Yahoo Finance
HeartSciences Inc. Signs First MyVista Insights Platform Customer - marketscreener.com
HeartSciences Signs First MyoVista Insights(TM) Platform Customer - marketscreener.com
HeartSciences (HSCS) Secures First Client for MyoVista Insights in the UK | HSCS Stock News - GuruFocus
HeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial Milestone - GlobeNewswire
HeartSciences amends corporate articles By Investing.com - Investing.com Canada
HeartSciences amends corporate articles - Investing.com
Heart Test Laboratories Announces $15M Securities Offering - TipRanks
Heart Test Labs Granted Nasdaq Compliance Extension - MSN
HeartSciences' CEO Andrew Simpson to Present at Emerging Growth Conference 82 on Wednesday, May 21, 2025 - The Manila Times
HeartSciences Unveils Game-Changing AI-Powered ECG Platform: CEO Presents Investment Opportunity Tomorrow - Stock Titan
HeartSciences receives Nasdaq compliance extension - Investing.com
HeartSciences to Host Investor Webinar and Q&A on Wednesday May 14, 2025Featuring CEO Andrew Simpson - The Manila Times
HeartSciences (HSCS) Enhances Team with Key Scientific Advisory Appointments | HSCS Stock News - GuruFocus
HeartSciences Inc. Expands Scientific Advisory Board with Three New Appointments to Enhance AI-Driven Cardiac Care - Nasdaq
HeartSciences Adds Prominent Key Advisors to its Scientific Advisory Board - The Manila Times
HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2025 Financial Results - ADVFN
HeartSciences launches MyoVista Insights platform - TipRanks
HeartSciences (HSCS) Unveils MyoVista Insights Platform | HSCS S - GuruFocus
HeartSciences (HSCS) Unveils MyoVista Insights Platform | HSCS Stock News - GuruFocus
HeartSciences Announces Launch of MyoVista Insights™ Platform and Related Early Adopter Program - The Manila Times
Lifestyle Icon Martha Stewart Confirmed As Vivid Sydney 2025's Global Storyteller - Barchart.com
This AI Company Is Solving A 100+ Year-Old Health Problem - Barchart.com
Northstar Secures 15-Year Lease Extension For Delta, BC Facility - Barchart.com
/R E P E A T -- LASSONDE INDUSTRIES INC. WILL HOLD A CONFERENCE CALL TO DISCUSS ITS Q4 AND FISCAL 2024 RESULTS/ - Barchart.com
HeartSciences faces Nasdaq delisting over equity shortfall By Investing.com - Investing.com Canada
HeartSciences faces Nasdaq delisting over equity shortfall - Investing.com
HeartSciences Reports Third Quarter Fiscal 2025 Financial Results and Business Update on AI-Powered ECG Innovations - Nasdaq
Finanzdaten der Heartsciences Inc-Aktie (HSCS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.54%
1.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):